Risk factors for the development of hematological toxicity during the application of weekly paclitaxel in breast cancer

Authors :: Lenny Gallardo
Germán Calderillo-Ruiz
Paula Cabrera-Galeana
Rafael Rodríguez-Ortiz
Alberto Alvarado-Miranda
Karla Itzel Aguilar-Flores
Source :: Gaceta Mexicana de Oncolog�a. 18
Publication Year :: 2022
Publisher :: Publicidad Permanyer, SLU, 2022.

Subjects :: Oncology
medicine.medical_specialty
Breast cancer
Hematological toxicity
business.industry
Internal medicine
medicine
Weekly paclitaxel
business
medicine.disease

Full Text Access

Tools